Dare Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Dare Bioscience using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $-0.28 | $-0.36 | 22.2 % |
| Q2 | 2025-08-14 | $-0.45 | $-0.57 | 21.1 % |
| Q1 | 2025-05-13 | $-0.50 | $-0.63 | 20.6 % |
| Q4 | 2025-03-31 | $-0.65 | $-0.63 | -3.17 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $2.26K | $21.85K | -89.6 % |
| Q2 | 2025-08-14 | $0 | $312.90K | -100.0 % |
| Q1 | 2025-05-13 | $25.43K | $600.00K | -95.8 % |
| Q4 | 2025-03-31 | $-63.65K | $1.00M | -106.4 % |
Dare Bioscience (DARE) is scheduled to report earnings on March 30, 2026. The last reported earnings were for reported on November 13, 2025 for Q3.
The Actual EPS was $-0.28, which beat the estimate of $-0.36.
The Actual Revenue was $2.3K, which missed the estimate of $21.9K.
Browse earnings estimates, EPS, and revenue on all stocks.